Name: LipiFlow Activator Clear (10-pack) Case
Brand: Johnson and Johnson
SKU: DER1999
Price: 1350.0 USD
Availability: InStock

Roll over image to zoom in Click on image to zoom

About the Product

TearScience Activator Clear is the sterile, single use disposable applied to the eye during a LipiFlow treatment. This SKU is the case of ten, model LFD-2100, catalog number 0803-5051. Each unit is packaged sterile and requires no sterilization before use, and it is a prescription device.

This is the single use disposable that a practice buys as a consumable for the LipiFlow Thermal Pulsation System, and it fits that system only. It has a translucent, vaulted design that sits over the eye, and a pair is placed over both eyes for a bilateral treatment. During the treatment the console delivers warmth and intermittent pressure through the Activator, with heat applied to the inner eyelid surface at 42.5 degrees Celsius. It is supplied sterile and is discarded after one patient.

What Is Included

10 single use TearScience Activator Clear applicators, supplied sterile, in one box

Specifications

Model	LFD-2100
Catalog number	0803-5051
Pack size	Box of 10
Fits	LipiFlow Thermal Pulsation System
Applied temperature	42.5 degrees Celsius at the inner eyelid
Sterility	Packaged sterile, no sterilization required before use
Reuse	Single use, discard after one patient
Prescription use	Yes

Regulatory

The Activator is the applicator for the LipiFlow Thermal Pulsation System. That system is a Class II device under product code ORZ, eyelid thermal pulsation system, 21 CFR 886.5200, cleared under 510(k) K192623 to TearScience, Inc. on 22 October 2019.

Cleared Indications for Use of the LipiFlow Thermal Pulsation System:

The LipiFlow Thermal Pulsation System is intended for the application of localized heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye.

RescueRating RR 63 out of 100 Evidence: ModerateHow we rated itHide details

RescueRating

How LipiFlow earned RR 63

Evidence: ModerateRated November 2026Next review February 2027

In-office product: rated on published research and doctor adoption, each scored out of 100 within in-office eyelid and gland procedures.

RR63

Published research759 scored studies; evidence moderate
Doctor adoption50#2 of 3 in in-office eyelid and gland procedures by units ordered

Published research75 / 100

What was studied: Heat and pressure therapy for the meibomian glands (cleared use)
Match to this product: Same formula or device: studies count in full

Meta-analysisCochrane Database Syst Rev, 2024

LipiFlow for the treatment of dry eye disease (Cochrane review)
13 RCTs; LipiFlow performed similarly to other MGD treatments, with conflicting symptom evidence versus warm compresses and slightly smaller OSDI gains than thermostatic devices; low to very low certainty.
Randomized trialOptom Vis Sci, 2022

Comparison of two thermal pulsation systems in the treatment of meibomian gland dysfunction: a randomized, multicenter study
iLux was noninferior to LipiFlow on gland score at 12 months; symptoms slightly favored iLux.
Meta-analysisGraefes Arch Clin Exp Ophthalmol, 2021

Efficacy and safety of a vectored thermal pulsation system (Lipiflow) in the treatment of MGD: a systematic review and meta-analysis
10 RCTs; improved OSDI, SPEED and gland function versus lid hygiene or no treatment, with heterogeneity from unit-of-analysis errors.
Randomized trialClin Ophthalmol, 2020

The efficacy between conventional lid hygiene and additional thermal pulsatile system in MGD patients on long-term anti-glaucoma medications: an RCT
No difference at 6 months between LipiFlow plus lid hygiene and lid hygiene alone in this glaucoma-medication population.

Study results describe the people studied. They do not predict how any one patient will respond.

Doctor adoption50 / 100

Rank in category: #2 of 3 by units ordered
Ordering practices: 41 in 92 days
Repeat orders: 17 repeat orders from 41 practices in 92 days
Window: 11 Aug to 10 Nov 2026

Orders and reorders from practices in the Dry Eye Rescue network only, ranked within in-office eyelid and gland procedures.

Sources and methodHow we got this

Research: peer-reviewed studies from PubMed and other medical indexes, scored by our clinical team on how closely each matches this product.
Doctor adoption: Dry Eye Rescue wholesale orders and reorders, ranked within in-office eyelid and gland procedures.
In-office products have no patient purchases or reviews, so the RescueRating averages research and doctor adoption.
Schedule: re-rated every quarter. Changes of 5 points or more are checked by our team before they go live.

How RescueRating works Questions: 561-468-8747

CLINIC ESSENTIALS